期刊文献+

血浆置换抢救妊娠导致血栓性血小板减少性紫癜1例 被引量:1

One case report of thrombotic thrombocytopenic purpura in pregnancy treated with plasma exchange
原文传递
导出
摘要 目的探讨血浆置换在抢救妊娠导致血栓性血小板减少性紫癜的临床治疗效果。方法使用血浆单采机于患者入院后单采血浆,1次/d,连续3 d,同时补充等量新鲜冰冻血浆和(或)血浆代用品。置换前24 h,置换1次、2次、3次及治疗后24 h、48 h血小板计数、红细胞计数、血红蛋白含量和患者出凝血时间、纤维蛋白原含量。结果完成治疗后,同治疗前进行比较,血小板计数由6×109/L升至70×109/L,红细胞计数由2. 03×1012/L升至2. 83×1012/L,血红蛋白由64g/L升至91g/L,出凝血时间均在正常范围内。结论血浆置换能迅速改善妊娠导致的血栓性血小板减少性紫癜微血管病性溶血性病变,减少血小板聚集性消耗,安全有效。 Objective To investigate the clinical effect of plasma exchange( PE) in thrombotic thrombocytopenic purpura pregnancy.Methods After the case was diagnosed,PE was performed daily,for a total of 3 times. The datas about blood routine examination and hemagglutination in different points were analyzed. Results Clinical symptoms were significantly improved in this patient. The count of Plt were increased from 6×109/L to 70×109/L,as the hemoglobin was increased from 64 g/L to 91 g/L. The change of hemagglutination was acceptable. Conclusion This case illustrates that plasma exchange wasefficacy and safetyinthrombotic thrombocytopenic purpura pregnancy. TPE has significantly decreased assemble of PLT and improved patients' microangiopathic hemolytic anemia caused by pregnancy.
作者 夏爱军 党娥 陈晓鹏 尹文 XIA Aijun;DANG E;CHEN Xiaopeng;YIN Wen(Department of TransfusionMedicine,Xijing Hospital,The Air Force Military Medical U-niversity,Xian 710032,China.)
出处 《中国输血杂志》 CAS 2018年第9期1040-1042,共3页 Chinese Journal of Blood Transfusion
关键词 血浆置换 血栓性血小板减少性紫癜 妊娠 therapeutic plasma exchange (TPE) thrombotic thrombocytopenic purpura ( TTP) pregnancy
  • 相关文献

参考文献8

二级参考文献118

  • 1秦燕,苏健,黄石兵,刘红.ADAMTS13活性及抑制物测定在ITTP诊断中的价值[J].南通大学学报(医学版),2009,29(6):437-438. 被引量:6
  • 2韩红,邹萍.血栓性血小板减少性紫癜及其研究进展[J].临床内科杂志,2007,24(2):142-144. 被引量:22
  • 3Crawley JT, de Groot R Xiang Y et ai, Unravelling the scissile bond: how ADAMTS13 recognizes and cleaves yon Willebrand factor[J]. Blood, 2011, 118(12) :3212-3221.
  • 4Kremer Hovinga JA, L/immle B. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura[J]. Hematology Am Soc Hematol Educ Program, 2012, 2012:610-616.
  • 5Lotta LA, Garagiola I, Palla R, eta]. ADAMTSI3 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura[J]. HumMutat, 2010, 31(1): 11-19.
  • 6Bettoni G, Palla R, Valsecchi C, et al. ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura[J]. J Thromb Haemost, 2012, 10(8):1556-1565,.
  • 7Andersson HM, Siegerink B, Luken BM, et al. High VWF, low ADAMTS13, and oral contraeeptives increase the risk of ischemie stroke and myocardial infarction in young women[J]. Blood, 2012, 119(6):1555-1560.
  • 8Bongers TN, de Bruijne EL, Dippel DW, et al. Lower levels ofADAMTS13 are associated with cardiovascular disease in young patients[J]. Atherosclerosis, 2009, 207(1) : 250-254.
  • 9Zhao BQ, Chauhan AK, Canault M, et al. yon Willebrand factor -cleaving protease ADAMTS13 reduces ischemie brain injury in experimental stroke[J]. Blood, 2009, 114(15): 3329- 3334.
  • 10Gandhi C, Khan MM, Lentz SR, et al. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice[J]. Blood, 2012, 119(10) :2385-2391.

共引文献27

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部